Last Updated: June 24, 2026

Suppliers and packagers for habitrol


✉ Email this page to a colleague

« Back to Dashboard


habitrol

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076 NDA Walgreens Company 0363-0451-74 14 PATCH in 1 CARTON (0363-0451-74) / 24 h in 1 PATCH 2015-09-01
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076 NDA Walgreens Company 0363-0455-70 7 PATCH in 1 CARTON (0363-0455-70) / 24 h in 1 PATCH 2015-09-01
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076 NDA Walgreens Company 0363-0455-74 14 PATCH in 1 CARTON (0363-0455-74) / 24 h in 1 PATCH 2015-09-01
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076 NDA Walgreens Company 0363-0457-74 14 PATCH in 1 CARTON (0363-0457-74) / 24 h in 1 PATCH 2015-09-01
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076 NDA Rugby Laboratories 0536-1106-52 7 PATCH in 1 CARTON (0536-1106-52) / 24 h in 1 PATCH 2016-04-01
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076 NDA Rugby Laboratories 0536-1106-88 14 PATCH in 1 CARTON (0536-1106-88) / 24 h in 1 PATCH 2016-04-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

HABITROL Suppliers: Who Makes the Transdermal Nicotine System and What to Verify in the Supply Chain

Last updated: May 28, 2026

HABITROL is a nicotine transdermal system (patch). Identifying “suppliers” in pharma usually means (1) the registered finished-dose manufacturer(s) that produce HABITROL for the NDA/label, (2) key component suppliers (nicotine, backing film, adhesive, rate-controlling membrane), and (3) logistics/wholesaler channels. Current public, citable specifics for HABITROL’s exact manufacturer-of-record and component sourcing are not provided in the prompt, so a complete and accurate supplier map cannot be produced.

What companies supply HABITROL (nicotine transdermal system) manufacturing and labeling?

Answer: Not enough verified data is provided to name the finished-dose manufacturing sites or the ingredient/component suppliers for HABITROL.

What is typically captured for “suppliers” on FDA labeling and Orange Book?

  • NDA/label “Manufactured for” and “Distributed by” text
  • Application holder and manufacturing changes over time
  • Orange Book listing entries that connect listed drug strength and dosage form to NDA and applicants
  • Site-specific FDA Establishment Registration and Drug Facility database entries

Which finished-dose manufacturers are listed for HABITROL on FDA records?

Answer: Not enough verified data is provided to name HABITROL finished-dose manufacturers.

What to check for supplier identity

  • FDA label “Manufactured for” section
  • Current Good Manufacturing Practice (cGMP) site registered in FDA’s establishment records
  • Packaging labeler versus manufacturer-of-record distinctions

Who supplies HABITROL active ingredient nicotine for the patch?

Answer: Not enough verified data is provided to name nicotine API suppliers used for HABITROL.

Typical nicotine supply chain nodes

  • Nicotine base production and purification
  • Nicotine salt/grade specifications for pharmaceutical patch formulations
  • Intermediate handling and solvent systems

What raw-material suppliers provide the HABITROL patch delivery components?

Answer: Not enough verified data is provided to name component suppliers for the patch.

Common component categories in transdermal nicotine systems

  • Backing film (occlusive layer)
  • Rate-controlling membrane
  • Pressure-sensitive adhesive system
  • Release liner
  • Patch dispensing housing/secondary packaging

What is the HABITROL supply chain risk profile if API or adhesive sourcing changes?

Answer: Not enough verified data is provided to map actual suppliers, so risk profiling tied to supplier concentration or dual-sourcing cannot be stated.

Typical risk levers for nicotine patches

  • Single-source adhesive or membrane suppliers
  • Lead-time sensitivity for backing film and sterile packaging components
  • Regulatory impacts from manufacturing site or formulation process changes

How to validate HABITROL suppliers for compliance and procurement?

Answer: Not enough verified data is provided to state the specific HABITROL supplier set.

Validation steps procurement teams usually run

  • Cross-check label “Manufactured for/Distributed by” against FDA establishment registrations
  • Match Orange Book applicant/NDA to labelholder manufacturing information
  • Request supplier declarations for GMP status and change control history

Key Takeaways

  • HABITROL is a nicotine transdermal patch, but the prompt does not provide verified label/FDA records needed to name the finished-dose manufacturer(s), API supplier(s), or patch component supplier(s).
  • Without those sources, an accurate supplier list cannot be produced.

FAQs

  1. Is HABITROL manufactured by the same company that owns the NDA/label?
  2. Which FDA database entries are used to identify the manufacturer-of-record for HABITROL?
  3. Do nicotine patch companies commonly use multiple adhesive suppliers, and how is that disclosed?
  4. Where on the HABITROL label can procurement teams find “manufactured for” and site details?
  5. How do manufacturing changes for nicotine patches show up in FDA records over time?

References (APA)

  1. U.S. Food and Drug Administration. Orange Book: Approved Drug Products.
  2. U.S. Food and Drug Administration. Drugs@FDA.
  3. U.S. Food and Drug Administration. Registration and Listing / Establishment Registration.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.